Next Article in Journal
Frameshifting in the P6 cDNA Phage Display System
Next Article in Special Issue
Fast and Sensitive LC-DAD-ESI/MS Method for Analysis of Saikosaponins c, a, and d from the Roots of Bupleurum Falcatum (Sandaochaihu)
Previous Article in Journal
Molecular Modeling Studies on 11H-Dibenz[b,e]azepine and Dibenz[b,f][1,4]oxazepine Derivatives as Potent Agonists of the Human TRPA1 Receptor
Previous Article in Special Issue
Antimicrobial Activity of Sphingolipids Isolated from the Stems of Cucumber (Cucumis sativus L.)
Molecules 2010, 15(12), 9340-9353; doi:10.3390/molecules15129340
Article

Evaluation of the Bioactivity of Novel Spiroisoxazoline TypeCompounds against Normal and Cancer Cell Lines

1,* , 2
, 1
, 2
 and 2
Received: 5 October 2010; in revised form: 3 November 2010 / Accepted: 2 December 2010 / Published: 17 December 2010
(This article belongs to the collection Bioactive Compounds)
Download PDF [163 KB, uploaded 18 June 2014]
Abstract: The aim of this study was to investigate the in vitro cellular activity of novel spiroisoxazoline type compounds against normal and cancer cell lines from lung tissue (Hs888Lu), neuron-phenotypic cells (SH-SY5Y), neuroblastoma (SH-SY5Y), human histiocytic lymphoma (U937), lung cancer (A549), and leukaemia (HL-60). Our bioassay program revealed that the spiroisoxazoline type compounds show cytotoxicity only in lymphoma cell lines, which is in contrast with the pyrrolidine precursor of these spiroisoxazoline compounds, where significant cytotoxicity is seen in all normal and cancer cell lines. These data suggest a tumour-specific mechanism of action. In addition these data also show that spiroisoxazoline compounds are non-toxic in the human neuronphenotypic neuroblastoma SH-SY5Y cell line, and furthermore that they might protect cells from neurodegenerative disease.
Keywords: pyrrolidine; spiroisoxazoline; cytotoxicity; neurotoxicity; neuroprotection pyrrolidine; spiroisoxazoline; cytotoxicity; neurotoxicity; neuroprotection
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Najim, N.; Bathich, Y.; Zain, M.M.; Hamzah, A.S.; Shaameri, Z. Evaluation of the Bioactivity of Novel Spiroisoxazoline TypeCompounds against Normal and Cancer Cell Lines. Molecules 2010, 15, 9340-9353.

AMA Style

Najim N, Bathich Y, Zain MM, Hamzah AS, Shaameri Z. Evaluation of the Bioactivity of Novel Spiroisoxazoline TypeCompounds against Normal and Cancer Cell Lines. Molecules. 2010; 15(12):9340-9353.

Chicago/Turabian Style

Najim, Nigar; Bathich, Yaser; Zain, Mazatulikhma Mat; Hamzah, Ahmad Sazali; Shaameri, Zurina. 2010. "Evaluation of the Bioactivity of Novel Spiroisoxazoline TypeCompounds against Normal and Cancer Cell Lines." Molecules 15, no. 12: 9340-9353.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert